Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Venbridge
TorontoSeed–Late Stage
1 person
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Growth
1 person
SymBiosis
BentonvilleSeed–Late Stage
4 people
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
E15
Hong KongPre-Seed–Late Stage
1 person
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
Panda Capital
Seed–Late Stage
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Ikarian Capital
DallasSeries A–Late Stage
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
Nissay Capital
TokyoPre-Seed–Growth
1 person
Oikos Ventures
MontevideoSeed–Growth
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
EMBRAPII
BrasíliaPre-Seed–Growth
Hefei High-tech VC
HefeiSeed–Series C
Seoul Investment Partners
SeoulSeed–Late Stage
Stonebridge Ventures
SeoulSeries A–Series C
3 people
GERBER-RAUTH
MilanPre-Seed–Late Stage
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
CDF-Capital
ShenzhenSeed–Late Stage
Hiroshima Innovation Network
HiroshimaPre-Seed–Growth
K2 Global
WilmingtonPre-Seed–Series C
3 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.














